Ductal neoplasia of the pancreas: Nosologic, clinicopathologic, and biologic aspects

Seminars in Radiation Oncology

Volumn 15, Issue 4 SPEC. ISS., 2005, Pages 254-264

  Adsay, Nazmi Volkan ^a,b   Basturk, Olca ^a   Cheng, Jeanette D ^a   Andea, Aleodor A ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Carcinogenesis; Carcinoma; Ductal; Intraepithelial; Molecular; Neoplasia; Pancreas

Indexed keywords

BRCA2 PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYCLIN D1; CYTOKERATIN; CYTOKERATIN 19; FASCIN; GLYCOPROTEIN; KI 67 ANTIGEN; MESOTHELIN PROTEIN; MUCIN; MUCIN 1; MUCIN 5; ONCOPROTEIN; PROSTATE STEM CELL ANTIGEN; PROTEIN 14 3 3; PROTEIN 14 3 3 SIGMA; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

BENIGN TUMOR; BIOLOGY; CANCER CLASSIFICATION; CANCER GENETICS; CANCER INFILTRATION; CARCINOGENESIS; COLLOID CARCINOMA; CYST FLUID; CYSTADENOMA; CYSTIC DUCT; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIUM TUMOR; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MEDULLARY CARCINOMA; MISMATCH REPAIR; MOLECULAR MECHANICS; ONCOGENE; ONCOGENE K RAS; ONCOGENE NEU; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS CYST; PANCREAS DUCT; PANCREAS TUMOR; PRECURSOR; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 25444471804     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2005.04.001     Document Type: Article

References (128)

1. D.S. Klimstra, N.V. Adsay Benign and malignant tumors of the pancreas R.D. Odze J.R. Goldblum J.M. Crawford Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas 2003 Saunders Philadelphia, PA 699 731
2. R.H. Hruban, C. Iacobuzio-Donahue, R.E. Wilentz Molecular pathology of pancreatic cancer Cancer J 7 2001 251 258
3. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra Pancreatic intraepithelial neoplasia A new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
4. F. Sessa, E. Solcia, C. Capella Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients Virchows Arch 425 1994 357 367
5. G. Kloppel, E. Solcia, D.S. Longnecker World Health Organization, International Histologic Classification of Tumors Histologic Typing of Tumors of the Exocrine Pancreas vol 2 1996 Springer Geneva
6. N.V. Adsay The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: Current concepts and controversies Surgery 133 2003 459 463
7. N.V. Adsay, C. Pierson, F. Sarkar Colloid (mucinous noncystic) carcinoma of the pancreas Am J Surg Pathol 25 2001 26 42
8. R.E. Wilentz, M. Goggins, M. Redston Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas A newly described and characterized entity Am J Pathol 156 2001 1641 1651
9. J. Luttges, G. Zamboni, G. Kloppel Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist Dig Surg 16 1999 291 296
10. J. Luttges, I. Vogel, M. Menke The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas Virchows Arch 433 1998 237 242
11. G. Kloppel, G. Bommer, K. Ruckert Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis Virchows Arch Pathol Anat Histol 387 1980 221 233
12. S.C. Sommers, S.A. Murphy, S. Warren Pancreatic duct hyperplasia and cancer Gastroenterology 27 1954 629 640
13. A. Andea, F. Sarkar, V.N. Adsay Clinicopathological correlates of pancreatic intraepithelial neoplasia A comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma Mod Pathol 16 2003 996 1006
14. A. Hoorens, K. Prenzel, N.R. Lemoine Undifferentiated carcinoma of the pancreas Analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin J Pathol 185 1998 53 60
15. W.H. Westra, P. Sturm, P. Drillenburg K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver Genetic evidence to support origin from the duct epithelium Am J Surg Pathol 22 1998 1247 1254
16. V. Adsay, F. Sarkar, V. Vaitkevicius Squamous cell and adenosquamous carcinomas of the pancreas A clinicopathologic analysis of 11 cases (abstract) Mod Pathol 13 2000 179A (abstr)
17. D.E. Kardon, L.D. Thompson, R.M. Przygodzki Adenosquamous carcinoma of the pancreas A clinicopathologic series of 25 cases Mod Pathol 14 2001 443 451
18. N.V. Adsay, K. Merati, H. Nassar Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas Am J Surg Pathol 27 2003 571 578
19. P. Tranchida, F. Hasteh, F. Sarkar Poorly differentiated neuroendocrine (small cell) carcinomas of the pancreas An analysis of 8 examples of a debated entity Mod Pathol 13 2000 190A (abstr)
20. R.E. Wilentz, M.S. Talamani, J. Albores-Saavedra Morphology accurately predicts behavior of mucinous cystic neoplasms of the pancreas Am J Surg Pathol 23 1999 1320 1327
21. R.E. Wilentz, J. Albores-Saavedra, R.H. Hruban Mucinous cystic neoplasms of the pancreas Semin Diagn Pathol 17 2000 31 43
22. L.D.R. Thompson, R.C. Becker, R.M. Pryzgodski Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low malignant potential) of the pancreas A clinicopathologic study of 130 cases Am J Surg Pathol 23 1999 1 16
23. G. Zamboni, A. Scarpa, G. Bogina Mucinous cystic tumors of the pancreas Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors Am J Surg Pathol 23 1999 410 422
24. M.G. Sarr, H.A. Carpenter, L.P. Prabhakar Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas Can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 231 2000 205 212
25. K. Lewandrowski, J. Lee, J. Southern Cyst fluid analysis in the differential diagnosis of pancreatic cysts A new approach to the preoperative assessment of pancreatic cystic lesions AJR Am J Roentgenol 164 1995 815 819
26. Intraductal papillary mucinous neoplasms of the pancreas an updated experience Ann Surg 239 2004 788 797 discussion 797-799
27. K. Ohhashi, Y. Murakami, T. Takekoshi Four cases of mucin producing cancer of the pancreas on specific findngs of the papilla of Vater Prog Dig Endosc 20 1982 348 351
28. A. Yanagisawa, K. Ohashi, M. Hori Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas A novel clinicopathological entity Jpn J Cancer Res 84 1993 474 479
29. N.V. Adsay, K.C. Conlon, S.Y. Zee Intraductal papillary-mucinous neoplasms of the pancreas An analysis of in situ and invasive carcinomas in 28 patients Cancer 94 2002 62 77
30. M. Sugiyama, Y. Izumisato, N. Abe Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 2003 1244 1249
31. M. Kobari, S. Egawa, K. Shibuya Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes Differences in clinical characteristics and surgical management Arch Surg 134 1999 1131 1136
32. R. Salvia, C. Fernandez-del Castillo, C. Bassi Main-duct intraductal papillary mucinous neoplasms of the pancreas Clinical predictors of malignancy and long-term survival following resection Ann Surg 239 2004 678 685 discussion 685-687
33. N.V. Adsay, D.S. Longnecker, D.S. Klimstra Pancreatic tumors with cystic dilatation of the ducts Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms Semin Diagn Pathol 17 2000 16 30
34. M.G. Sarr, M. Murr, T.C. Smyrk Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions J Gastrointest Surg 7 2003 417 428
35. N.V. Adsay, K. Merati, O. Basturk Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms Delineation of an "intestinal" pathway of carcinogenesis in the pancreas Am J Surg Pathol 28 2004 839 848
36. N.V. Adsay, C.F. Adair, C.S. Heffess Intraductal oncocytic papillary neoplasms of the pancreas Am J Surg Pathol 20 1996 980 994
37. C.C. Compton Serous cystic tumors of the pancreas Semin Diagn Pathol 17 2000 43 56
38. O. Strobel, K. Z'Graggen, F.H. Schmitz-Winnenthal Risk of malignancy in serous cystic neoplasms of the pancreas Digestion 68 2003 24 33
39. I.J. Balcom, C. Fernandez-Del Castillo, A.L. Warshaw Cystic lesions in the pancreas When to watch, when to resect Curr Gastroenterol Rep 2 2000 152 158
40. R.H. Hruban, G.M. Petersen, P.K. Ha Genetics of pancreatic cancer. From genes to families Surg Oncol Clin North Am 7 1998 1 23
41. E. Rozenblum, M. Schutte, M. Goggins Tumor-suppressive pathways in pancreatic carcinoma Cancer Res 57 1997 1731 1734
42. R.H. Hruban, M. Goggins, J. Parsons Progression model for pancreatic cancer Clin Cancer Res 6 2000 2969 2972
43. R.H. Hruban, R.E. Wilentz, S.E. Kern Genetic progression in the pancreatic ducts Am J Pathol 156 2000 1821 1825
44. R.H. Hruban, R.E. Wilentz, M. Goggins Pathology of incipient pancreatic cancer Ann Oncol 10 suppl 4 1999 9 11
45. C.M. Barton, S.L. Staddon, C.M. Hughes Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 64 1991 1076 1082
46. S.Y. Zhang, B. Ruggeri, P. Agarwal Immunohistochemical analysis of p53 expression in human pancreatic carcinomas Arch Pathol Lab Med 118 1994 150 154
47. J.A. DiGiuseppe, R.H. Hruban, S.N. Goodman Overexpression of p53 protein in adenocarcinoma of the pancreas Am J Clin Pathol 101 1994 684 688
48. C.R. Boschman, S. Stryker, J.K. Reddy Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas Am J Pathol 145 1994 1291 1295
49. S.A. Hahn, S.E. Kern Molecular genetics of exocrine pancreatic neoplasms Surg Clin North Am 75 1995 857 869
50. B. Ruggeri, S.Y. Zhang, J. Caamano Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes Oncogene 7 1992 1503 1511
51. P.S. Moore, B. Sipos, S. Orlandini Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4 Virchows Arch 439 2001 798 802
52. P.S. Moore, S. Orlandini, G. Zamboni Pancreatic tumours molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis Br J Cancer 84 2001 253 262
53. M.S. Redston, C. Caldas, A.B. Seymour p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in Dna microdeletions Cancer Res 54 1994 3025 3033
54. G. Berrozpe, J. Schaeffer, M.A. Peinado Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer Int J Cancer 58 1994 185 191
55. D. Coppola, L. Lu, J.P. Fruehauf Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas TGF-beta1 protein expression predicts longer survival Am J Clin Pathol 110 1998 16 23
56. E.U. Lee, M.L. Cibull, E. O'Daniel-Pierce Expression of p53 protein in pancreatic adenocarcinoma. Relationship to cigaret smoking Int J Pancreatol 17 1995 237 242
57. J. Lundin, S. Nordling, K. von Boguslawsky Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer Oncology 53 1996 104 111
58. A. Scarpa, P. Capelli, K. Mukai Pancreatic adenocarcinomas frequently show p53 gene mutations Am J Pathol 142 1993 1534 1543
59. E. Heinmoller, W. Dietmaier, H. Zirngibl Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma Am J Pathol 157 2000 83 92
60. H. Kalthoff, W. Schmiegel, C. Roeder p53 and K-RAS alterations in pancreatic epithelial cell lesions Oncogene 8 1993 289 298
61. N.S. Pellegata, F. Sessa, B. Renault K-ras and p53 gene mutations in pancreatic cancer Ductal and nonductal tumors progress through different genetic lesions Cancer Res 54 1994 1556 1560
62. S. Nakamori, K. Yashima, Y. Murakami Association of p53 gene mutations with short survival in pancreatic adenocarcinoma Jpn J Cancer Res 86 1995 174 181
63. K. Weyrer, H. Feichtinger, M. Haun p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas Lab Invest 74 1996 279 289
64. J.A. DiGiuseppe, R.H. Hruban, G.J. Offerhaus Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma [see comments] Am J Pathol 144 1994 889 895
65. S.A. Hahn, A.T. Hoque, C.A. Moskaluk Homozygous deletion map at 18q21.1 in pancreatic cancer Cancer Res 56 1996 490 494
66. M. Schutte DPC4/SMAD4 gene alterations in human cancer, and their functional implications Ann Oncol 10 suppl 4 1999 56 59
67. R.E. Wilentz, G.H. Su, J.L. Dai Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas A new marker of DPC4 inactivation Am J Pathol 156 2000 37 43
68. M. Schutte, R.H. Hruban, L. Hedrick DPC4 gene in various tumor types Cancer Res 56 1996 2527 2530
69. D. Bartsch, D.W. Shevlin, W.S. Tung Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas Genes Chromosomes Cancer 14 1995 189 195
70. D. Bartsch, D.W. Shevlin, M.P. Callery Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation J Natl Cancer Inst 88 1996 680 682
71. C. Caldas, S.A. Hahn, L.T. da Costa Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
72. Y.X. Hu, H. Watanabe, K. Ohtsubo Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma Clin Cancer Res 3 1997 1473 1477
73. L. Huang, T.L. Goodrow, S.Y. Zhang Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas Cancer Res 56 1996 1137 1141
74. M. Naumann, N. Savitskaia, C. Eilert Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors Gastroenterology 110 1996 1215 1224
75. M. Schutte, R.H. Hruban, J. Geradts Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126 3130
76. A. Merlo, J.G. Herman, L. Mao 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 1995 686 692
77. T. Ueki, M. Toyota, T. Sohn Hypermethylation of multiple genes in pancreatic adenocarcinoma Cancer Res 60 2000 1835 1839
78. J. Geradts, R.H. Hruban, M. Schutte Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies Appl Immunohistochem Mol Morphol 8 2000 71 79
79. M. Goggins, M. Schutte, J. Lu Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 1996 5360 5364
80. H. Ozcelik, B. Schmocker, N. Di Nicola Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1997 17 18
81. K.W. Kinzler, B. Vogelstein Cancer-susceptibility genes. Gatekeepers and caretakers Nature 386 1997 761 763
82. M.S. van der Heijden, C.J. Yeo, R.H. Hruban Fanconi anemia gene mutations in young-onset pancreatic cancer Cancer Res 63 2003 2585 2588
83. G.H. Su, R.H. Hruban, R.K. Bansal Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers Am J Pathol 154 1999 1835 1840
84. G.H. Su, R. Bansal, K.M. Murphy ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma Proc Natl Acad Sci U S A 98 2001 3254 3257
85. G.H. Su, W. Hilgers, M.C. Shekher Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene Cancer Res 58 1998 2339 2342
86. M. Goggins, M. Shekher, K. Turnacioglu Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas Cancer Res 58 1998 5329 5332
87. D.D. De Vries, L.N. Went, G.W. Bruyn Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia Am J Hum Genet 58 1996 703 711
88. R.H. Hruban, A.D. van Mansfeld, G.J. Offerhaus K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization Am J Pathol 143 1993 545 554
89. M. Mariyama, K. Kishi, K. Nakamura Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients Jpn J Cancer Res 80 1989 622 626
90. K. Motojima, T. Urano, Y. Nagata Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma Ann Surg 217 1993 138 143
91. A. Scarpa, P. Capelli, A. Villaneuva Pancreatic cancer in Europe Ki-ras gene mutation pattern shows geographical differences Int J Cancer 57 1994 167 171
92. V.T. Smit, A.J. Boot, A.M. Smits KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas Nucleic Acids Res 16 1988 7773 7782
93. C. Almoguera, D. Shibata, K. Forrester Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
94. J. Luttges, A. Diederichs, M.A. Menke Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53 Cancer 88 2000 2495 2504
95. P.G. Terhune, D.M. Phifer, T.D. Tosteson K-ras mutation in focal proliferative lesions of human pancreas Cancer Epidemiol Biomarkers Prev 7 1998 515 521
96. M. Tada, M. Omata, S. Kawai Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Res 53 1993 2472 2474
97. M. Tada, M. Ohashi, Y. Shiratori Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease Gastroenterology 110 1996 227 231
98. C. Moskaluk, R.H. Hruban, S.E. Kern p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140 2143
99. J.Q. Cheng, B. Ruggeri, W.M. Klein Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc Natl Acad Sci U S A 93 1996 3636 3641
100. B.A. Ruggeri, L. Huang, M. Wood Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas Mol Carcinog 21 1998 81 86
101. C. Wallrapp, F. Muller-Pillasch, S. Solinas-Toldo Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene Cancer Res 57 1997 3135 3139
102. K. Satoh, H. Sasano, T. Shimosegawa An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas Cancer 72 1993 51 56
103. P.A. Hall, C.M. Hughes, S.L. Staddon The c-erb B-2 proto-oncogene in human pancreatic cancer J Pathol 161 1990 195 200
104. J.D. Day, J.A. Digiuseppe, C. Yeo Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms Human Pathology 27 1996 119 124
105. R.E. Wilentz, M. Goggins, M. Redston Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas A newly described and characterized entity Am J Pathol 156 2000 1641 1651
106. M. Goggins, G.J. Offerhaus, W. Hilgers Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ Am J Pathol 152 1998 1501 1507
107. M.A. Hollingsworth, J.M. Strawhecker, T.C. Caffrey Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines Int J Cancer 57 1994 198 203
108. Y. Li, D. Kufe The Human DF3/MUC1 carcinoma-associated antigen signals nuclear localization of the catenin p120(ctn) Biochem Biophys Res Commun 281 2001 440 443
109. Y. Makiguchi, Y. Hinoda, K. Imai Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth Jpn J Cancer Res 87 1996 505 511
110. S. Satoh, Y. Hinoda, T. Hayashi Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule Int J Cancer 88 2000 507 518
111. T. Terada, T. Ohta, M. Sasaki Expression of MUC apomucins in normal pancreas and pancreatic tumours J Pathol 180 1996 160 165
112. J.C. Byrd, J.J. Ho, D.T. Lamport Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins Cancer Res 51 1991 1026 1033
113. A. Allen, D.A. Hutton, J.P. Pearson The MUC2 gene product a human intestinal mucin Int J Biochem Cell Biol 30 1998 797 801
114. N.V. Adsay, K. Merati, A. Andea The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas Differential MUC1 and MUC2 expression supports the existence of two separate pathways of carcinogenesis Mod Pathol 15 2002 1087 1095
115. A. Andea, L. Tang, A. Suriawinata Adenocarcinoma progression analysis in pancreatic intraductal papillary mucinous neoplasms using tissue microarrays Mod Pathol 18 2005 273A (abstr)
116. H.U. Park, J.W. Kim, G.E. Kim Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia Pancreas 26 2003 e48 e54
117. J.J. Ho, S.W. Han, P.L. Pan Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells Int J Oncol 22 2003 273 279
118. G.E. Kim, H.I. Bae, H.U. Park Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas Gastroenterology 123 2002 1052 1060
119. A. Maitra, N.V. Adsay, P. Argani Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray Mod Pathol 16 2003 902 912
120. C.A. Iacobuzio-Donahue, A. Maitra, G.L. Shen-Ong Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol 160 2002 1239 1249
121. C.A. Iacobuzio-Donahue, A. Maitra, M. Olsen Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 2003 1151 1162
122. B. Ryu, J. Jones, M.A. Hollingsworth Invasion-specific genes in malignancy Serial analysis of gene expression comparisons of primary and passaged cancers Cancer Res 61 2001 1833 1838
123. B. Ryu, J. Jones, N.J. Blades Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression Cancer Res 62 2002 819 826
124. P. Argani, C. Rosty, R.E. Reiter Discovery of new markers of cancer through serial analysis of gene expression Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma Cancer Res 61 2001 4320 4324
125. P. Argani, C. Iacobuzio-Donahue, B. Ryu Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) Clin Cancer Res 7 2001 3862 3868
126. A. Maitra, C. Iacobuzio-Donahue, A. Rahman Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays Sea urchin fascin homolog and heat shock protein 47 Am J Clin Pathol 118 2002 52 59
127. C. Rosty, T. Ueki, P. Argani Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation Am J Pathol 160 2002 45 50
128. C.A. Iacobuzio-Donahue, R.H. Hruban Gene expression in neoplasms of the pancreas Applications to diagnostic pathology Adv Anat Pathol 10 2003 125 134